Lomustine with or without reirradiation for first progression of glioblastoma, LEGATO, EORTC-2227-BTG: study protocol for a randomized phase III study

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Trials

Topics

Medicine

Cancer Oncology

Internal Medicine

Surgery

Genetics

Show all topics

DOI

10.1186/s13063-024-08213-7

License

CC-BY

Other Formats

PDF